This inventor holds 2 USPTO granted patents. Top assignee: University of Ghent. Active years: 2005-2011.
Location History:
- Ghent, BE (2005)
- Zwijnaarde, BE (2011)
Company Filing History:
Years Active: 2005-2011
Title: Eric Maximilien Veys: Innovator in Cellular Matrices and Osteoarthritis Treatment
Introduction
Eric Maximilien Veys is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative methods for treating osteochondral defects and osteoarthritis. With a total of 2 patents, Veys is recognized for his pioneering work in utilizing polysulphated compounds in medical applications.
Latest Patents
Veys' latest patents include two groundbreaking inventions. The first patent, titled "Use of polysulphated alginate in cellular matrices," describes an in vitro/ex vivo method for cultivating connective tissue cells or progenitor cells, such as chondrogenic cells, in a matrix comprising polysulphated alginate. This innovative method allows for the preparation of a medicament aimed at treating or preventing osteochondral defects. The second patent, "Use of polysulphated cyclodextrins for treating osteoarthritis," relates to a method of using polysulphated cyclodextrins or their addition salts for treating arthrosis, along with the pharmaceutical compositions derived from this method.
Career Highlights
Eric Maximilien Veys is affiliated with Universiteit Gent, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in the treatment of joint-related ailments. Veys' dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
One of Veys' notable collaborators is August Verbruggen. Their partnership has likely fostered the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Eric Maximilien Veys is a distinguished inventor whose work in cellular matrices and osteoarthritis treatment showcases his commitment to advancing medical science. His patents reflect a deep understanding of biomedical applications, and his contributions continue to influence the field.